CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaler for COPD shows promise in early trial
Disease control TerminatedThis study tested a new inhaled medicine called HRG2005 in people with moderate to severe chronic obstructive pulmonary disease (COPD). About 82 participants were enrolled to see if the drug improves lung function compared to an active control. The trial was terminated early, so …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
Probiotic study for diabetes and COPD halted early
Disease control TerminatedThis study aimed to see if taking probiotics alongside standard treatment could lower blood sugar and improve lung function in adults aged 50-85 with both type 2 diabetes and chronic obstructive pulmonary disease (COPD). The trial was a small, early-stage study with 30 participan…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated May 17, 2026 00:26 UTC
-
New COPD combo therapy falls short in major trial
Disease control TerminatedThis study tested whether adding an experimental inhaler (CHF6001) to standard triple therapy could reduce flare-ups in people with severe COPD and chronic bronchitis. It included nearly 4,000 adults aged 40 and older who were current or former smokers. The trial was stopped earl…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New COPD inhaler combo studied to cut Flare-Ups
Disease control TerminatedThis study tested whether adding an experimental inhaler (CHF6001) to standard triple therapy could reduce flare-ups in people with COPD and chronic bronchitis. It involved about 4,700 adults aged 40 and older who were current or former smokers with moderate to severe COPD. The t…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
Inhaled Mucus-Targeting drug tested for asthma and COPD – study halted early
Disease control TerminatedThis study tested an inhaled drug called ARO-MUC5AC in healthy people and those with moderate-to-severe asthma or COPD. The goal was to see if it is safe and how the body processes it. The study was stopped early, so results are limited. About 78 people were planned to take part.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Lung drug study cut short: what we learned
Disease control TerminatedThis study looked at the safety of an inhaled medicine called treprostinil for people with both chronic obstructive pulmonary disease (COPD) and high blood pressure in the lungs (pulmonary hypertension). It included 41 adults who had already completed a previous study. The study …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Can rehab at home rival the clinic for COPD patients?
Symptom relief TerminatedThis study looked at whether doing breathing exercises at home works as well as doing them at a clinic for people with chronic obstructive pulmonary disease (COPD). The goal was to see if home rehab could improve exercise ability just as much. The study also checked costs, patien…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated May 17, 2026 00:27 UTC
-
Bringing comfort home: palliative care study aims to ease suffering
Symptom relief TerminatedThis study tested whether providing palliative care at home, through primary care clinics, helps seriously ill patients with cancer, heart failure, or COPD feel better. About 35 patients were enrolled, and researchers measured symptoms, anxiety, and depression. The goal was to im…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated May 07, 2026 18:38 UTC
-
AI listens to lungs: new study aims to detect disease by sound alone
Knowledge-focused TerminatedThis study tested whether artificial intelligence could detect and measure abnormal lung sounds in people with cystic fibrosis, COPD, or pulmonary fibrosis. Researchers used an electronic stethoscope to record breathing sounds during routine checkups and analyzed them with AI. Th…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC